High-tech patient care with a multidisciplinary approach to treatment of cancer is the hallmark of the Willis-Knighton Cancer Center. The center offers patients:
We treat the following cancers: prostate, lung, breast, colo-rectal, gynecologic (ovarian, cervical, vulvar, endometrial, etc.), hepatobilliary (liver, pancreas, etc.), head and neck.
Willis-Knighton Cancer Center is now offering Optune, a medical device that, when used in conjunction with partial-brain radiotherapy and chemotherapy, has been shown to extend overall survival and progression-free survival of newly diagnosed patients with glioblastoma multiforme (GBM). Optune is a portable, noninvasive device that delivers low-intensity, alternating electric fields (referred to as Tumor Treating Fields) that inhibit cancer cell replication and cause cancer cells to die.
Patients at Willis-Knighton Cancer Center can be confident about the quality of their case as the Willis-Knighton Cancer Center exceeds both state and national standards.
More Cancer Center News